Crafting cancer combinations
20:00 EDT 13 Jun 2012 | BioCentury
Two groups have developed platforms that could improve the identification of cancer drug combinations. A UNC team is using chemical proteomics to rationally design kinase inhibitor combinations that block resistance …
Original Article: Crafting cancer combinations
More From BioPortfolio on "Crafting cancer combinations"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
